CALCOCO2 and myeloid sarcoma: In conclusion, this work leads to propose a model in which the variant G140E of NDP52 may prevent the release of pro-inflammatory cytokines from B cells (and maybe mitochondrial factors such as mtDNA) known to trigger inflammation in MS patients.